Normal view MARC view ISBD view

Effect of increasing heart rate on left ventricular performance in patients with normal cardiac function. [electronic resource]

By:

Schaefer, S

Contributor(s):

Producer: 19880331Description: 617-20 p. digitalISSN:

0002-9149

Subject(s):

Online resources:

Available from publisher's website

In: The American journal of cardiology vol. 61

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

1 Severe neurotoxicity caused by gemcitabine treatment.
by Larsen, Finn Ole
2 Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer: A Phase II Study.
by Larsen, Finn Ole
3 Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.
by Larsen, Finn Ole
4 Systematic review: Incidence, risk factors, survival and treatment of bone metastases from colorectal cancer.
by Christensen, Troels Dreier
5 Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma.
by Larsen, Finn Ole
6 A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/- targeted therapy.
by Nielsen, Dorte Lisbet
7 Safety and feasibility of home-based chemotherapy.
by Larsen, Finn Ole
8 Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review.
by Røed Skårderud, Maria
9 Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer.
by Larsen, Finn Ole
10 Incidence and risk factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer.
by Polk, Anne
11 Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.
by Larsen, Finn Ole
12 Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.
by Christensen, Troels Dreier
13 Risk factors for brain metastases in patients with metastatic colorectal cancer.
by Christensen, Troels Dreier
14 Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.
by Larsen, Finn Ole
15 Capecitabine and Oxaliplatin Before, During, and After Radiotherapy for High-Risk Rectal Cancer.
by Larsen, Finn Ole
16 Engaging the older cancer patient; Patient Activation through Counseling, Exercise and Mobilization - Pancreatic, Biliary tract and Lung cancer (PACE-Mobil-PBL) - study protocol of a randomized controlled trial.
by Mikkelsen, Marta Kramer
17 Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer.
by Kalanxhi, Erta
18 Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
by Meltzer, Sebastian